newsfilter
← Latest News
PR Newswire·

Ampio Pharmaceuticals to Participate at the 34th Annual Roth Conference

ENGLEWOOD, Colo., March 9, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE:AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for the treatment of pain resulting from osteoarthritis, will attend the 34t